Literature DB >> 19460359

The up-regulation of microRNA-335 is associated with lipid metabolism in liver and white adipose tissue of genetically obese mice.

Noriko Nakanishi1, Yoshimi Nakagawa, Naoko Tokushige, Naohito Aoki, Takashi Matsuzaka, Kiyoaki Ishii, Naoya Yahagi, Kazuto Kobayashi, Shigeru Yatoh, Akimitsu Takahashi, Hiroaki Suzuki, Osamu Urayama, Nobuhiro Yamada, Hitoshi Shimano.   

Abstract

MicroRNAs (miRNAs) are short non-coding RNA that post-transcriptionally regulates gene expression. Some miRNAs have been proposed to be associated with obesity. However, miRNAs, which are related to the development of obesity in vivo remains unknown. Here in, we found the up-regulation of miR-335 in obesity using microarray analysis for miRNA. The expressions of miR-335 in liver and white adipose tissue (WAT) were up-regulated in obese mice including ob/ob, db/db, and KKAy mice. Increased miR-335 expressions were associated with an elevated body, liver and WAT weight, and hepatic triglyceride and cholesterol. Furthermore, miR-335 levels were closely correlated with expression levels of adipocyte differentiation markers such as PPARgamma, aP2, and FAS in 3T3-L1 adipocyte. These findings provide the first evidence that the up-regulated expressions of miR-335 in liver and WAT of obese mice might contribute to the pathophysiology of obesity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19460359     DOI: 10.1016/j.bbrc.2009.05.058

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  66 in total

Review 1.  Post-transcriptional regulation in metabolic diseases.

Authors:  Wook Kim; Eun Kyung Lee
Journal:  RNA Biol       Date:  2012-06-01       Impact factor: 4.652

Review 2.  MicroRNA control of bone formation and homeostasis.

Authors:  Jane B Lian; Gary S Stein; Andre J van Wijnen; Janet L Stein; Mohammad Q Hassan; Tripti Gaur; Ying Zhang
Journal:  Nat Rev Endocrinol       Date:  2012-01-31       Impact factor: 43.330

Review 3.  MicroRNAs and liver disease.

Authors:  Thomas A Kerr; Kevin M Korenblat; Nicholas O Davidson
Journal:  Transl Res       Date:  2011-02-02       Impact factor: 7.012

Review 4.  Regulation of cholesterol homeostasis.

Authors:  Leigh Goedeke; Carlos Fernández-Hernando
Journal:  Cell Mol Life Sci       Date:  2011-10-19       Impact factor: 9.261

5.  MicroRNAs and Cardiovascular Disease.

Authors:  Carlos Fernández-Hernando; Angel Baldán
Journal:  Curr Genet Med Rep       Date:  2013-03

6.  Obesity-induced overexpression of miR-802 impairs glucose metabolism through silencing of Hnf1b.

Authors:  Jan-Wilhelm Kornfeld; Catherina Baitzel; A Christine Könner; Hayley T Nicholls; Merly C Vogt; Karolin Herrmanns; Ludger Scheja; Cécile Haumaitre; Anna M Wolf; Uwe Knippschild; Jost Seibler; Silvia Cereghini; Joerg Heeren; Markus Stoffel; Jens C Brüning
Journal:  Nature       Date:  2013-02-07       Impact factor: 49.962

7.  The effect of miRNA-122 in regulating fat deposition in a cell line model.

Authors:  Yu-Qiang Nie; Jie Cao; Yong-Jian Zhou; Xia Liang; Yan-Lei Du; Yu-Jui Yvonne Wan; Yu-Yuan Li
Journal:  J Cell Biochem       Date:  2014-05       Impact factor: 4.429

Review 8.  MicroRNAs in metabolic disease.

Authors:  Carlos Fernández-Hernando; Cristina M Ramírez; Leigh Goedeke; Yajaira Suárez
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-02       Impact factor: 8.311

9.  MicroRNA-335 acts as a candidate tumor suppressor in prostate cancer.

Authors:  Si-wei Xiong; Tian-xin Lin; Ke-wei Xu; Wen Dong; Xiao-hui Ling; Fu-neng Jiang; Guo Chen; Wei-de Zhong; Jian Huang
Journal:  Pathol Oncol Res       Date:  2013-03-03       Impact factor: 3.201

10.  The glypican 3-hosted murine mir717 gene: sequence conservation, seed region polymorphisms and putative targets.

Authors:  Tanja Kunej; Dasa Jevsinek Skok; Simon Horvat; Peter Dovc; Zhihua Jiang
Journal:  Int J Biol Sci       Date:  2010-12-02       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.